ArticleInternational journal of women's health2026
Global Trends and Burden of Non-Neoplastic Gynecologic Diseases Among Women of Childbearing Age, 1990-2021: a GBD 2021 Analysis.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Non-neoplastic gynecological diseases substantially impact women of childbearing age (WCBA), contributing to global burden. Despite growing awareness, disparities in healthcare access remain widespread across regions and socioeconomic groups. Materials and Methods: Utilizing data from the Global Burden of Disease Study 2021, the study assess the prevalence and disability-adjusted life years (DALYs) of 7 non-neoplastic gynecological diseases in WCBA across 231 countries and regions from 1990 to 2021. Age-standardised rates (ASRs) and estimated annual percentage changes (EAPCs) were used to assess temporal trends. Additionally, the socio-demographic index (SDI) was explored for its association with disease burden. Results: From 1990 to 2021, global age-standardised prevalence and DALY rates of the non-neoplastic gynecological diseases remained relatively stable (EAPC: 0.00%, -0.20%). In contrast, the absolute number of prevalent cases increased markedly, largely reflecting population growth and changes in age structure. Female infertility and polycystic ovary syndrome (PCOS) demonstrated increasing trends in both prevalence (EAPC: 0.69%, 0.74%) and DALYs (EAPC: 0.71%, 0.72%). In 2021, premenstrual syndrome (PMS) showed the highest prevalence (889.97 per 100,000) and DALY rate (74.27 per 100,000). North Africa and Middle East showed the highest ASR of prevalence (ASPR, 70,265.65) and DALYs (ASDR, 1,812.41) globally. Age-specific analyses indicated that prevalence and DALYs peaked among women aged 35-44 years. In addition, higher SDI correlated with lower ASPR and ASDR in overall non-neoplastic gynecological diseases, while PCOS exhibited upward trends. Conclusion: The global burden of non-neoplastic gynecological diseases among WCBA remains substantial, with marked heterogeneity across regions and conditions. These findings underscore the importance of strengthened disease surveillance, improved and equitable access to reproductive health services, and greater integration of mental health support in women's health strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.